histone variant macroh2a suppresses melanoma progression regulation cdk8
cancer disease consisting genetic epigenetic changes although increasing evidence demonstrates tumour progression entails chromatin-mediated changes dna methylation role histone variants cancer initiation progression currently remains unclear histone variants replace conventional histones within nucleosome confer unique biological functions chromatin- report histone variant macroh2a mh2a suppresses tumour progression malignant melanoma loss mh2a isoforms histone variants generally associated condensed chromatin fine-tuning developmental gene expression programs- positively correlated increasing malignant phenotype melanoma cells culture human tissue samples knockdown mh2a isoforms melanoma cells low malignancy results significantly increased proliferation migration vitro growth metastasis vivo restored expression mh2a isoforms rescues malignant phenotypes vitro vivo demonstrate tumour-promoting function mh2a loss mediated least part direct transcriptional upregulation cdk8 suppression cdk8 colorectal cancer oncogene inhibits proliferation melanoma cells knockdown cdk8 cells depleted mh2a suppresses proliferative advantage induced mh2a loss moreover significant inverse correlation mh2a cdk8 expression levels exists melanoma patient samples taken together results demonstrate mh2a critical component chromatin suppresses development malignant melanoma highly intractable cutaneous neoplasm
